In our study, lncRNA CRNDE inhibited EMTs in lung epithelial cells via the downregulation of the miR-29a-3p/MCL-1 axis, which resulted in Th17/IL-17A effects that reduced asthma signs (Figure 7). Here, IL17A is linked to asthma.